Eikon Therapeutics, Inc. (EIKN) stock
EIKNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$5.15−0.23 (-4.36%)
Close on Nov 17, 2026Market cap $278.95MP/E –Yield –
Eikon Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Eikon Therapeutics's total assets was $779.57M at Jun 30, 2026. For fiscal 2025 it was $594.73M.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $594.73M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $779.57M | – |
| Q1 FY2026 | Mar 31, 2026 | $850.83M | – |
| Q4 FY2025 | Dec 31, 2025 | $594.73M | – |
See a number that looks wrong?